[HTML][HTML] Glycyrrhizic acid for COVID-19: findings of targeting pivotal inflammatory pathways triggered by SARS-CoV-2

W Zheng, X Huang, Y Lai, X Liu, Y Jiang… - Frontiers in …, 2021 - frontiersin.org
Background: Coronavirus disease 2019 (COVID-19) is now a worldwide public health crisis.
The causative pathogen is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

[HTML][HTML] Glycyrrhizic acid: a natural plant ingredient as a drug candidate to treat COVID-19

Z Sun, G He, N Huang, K Thilakavathy… - Frontiers in …, 2021 - frontiersin.org
The total number of cumulative cases and deaths from the COVID-19 pandemic caused by
SARS-CoV-2 is still increasing worldwide. Although many countries have actively …

Glycyrrhetinic acid: A potential drug for the treatment of COVID-19 cytokine storm

H Li, J You, X Yang, Y Wei, L Zheng, Y Zhao, Y Huang… - Phytomedicine, 2022 - Elsevier
Background The cytokine storm (CS) triggered by coronavirus disease 2019 (COVID-19)
has caused serious harm to health of humanity and huge economic burden to the world, and …

[HTML][HTML] In silico prediction of molecular targets of astragaloside IV for alleviation of COVID-19 hyperinflammation by systems network pharmacology and bioinformatic …

C Ge, Y He - Frontiers in pharmacology, 2020 - frontiersin.org
Introduction The overproduction of cytokines and chemokines caused by excessive and
uncontrolled inflammation contributes to the development of COVID-19. Astragaloside IV is …

Integrative pharmacological mechanism of vitamin C combined with glycyrrhizic acid against COVID-19: findings of bioinformatics analyses

R Li, K Wu, Y Li, X Liang, KP Lai… - Briefings in …, 2021 - academic.oup.com
Abstract Objective Coronavirus disease 2019 (COVID-19) is a fatal and fast-spreading viral
infection. To date, the number of COVID-19 patients worldwide has crossed over six million …

Traditional uses, pharmacological effects, and molecular mechanisms of licorice in potential therapy of COVID-19

Q Zhang, H Huang, M Qiu, Z Wu, Z Xin, X Cai… - Frontiers in …, 2021 - frontiersin.org
The current Coronavirus disease 2019 (COVID-19) pandemic has become a global
challenge, and although vaccines have been developed, it is expected that mild to moderate …

Network pharmacology and molecular docking analysis on mechanisms of Tibetan Hongjingtian (Rhodiola crenulata) in the treatment of COVID-19

L Wang, Y Wang, W Yang, X He… - Journal of medical …, 2021 - microbiologyresearch.org
Introduction. Coronavirus disease 2019 (COVID-19) is a highly contagious disease and
ravages the world. Hypothesis/Gap Statement. We proposed that R. crenulata might have …

Pharmacological perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19

P Luo, D Liu, J Li - International Journal of Antimicrobial Agents, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) caused by the previously unknown
pathogen, severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) is now a …

EGCG, a green tea catechin, as a potential therapeutic agent for symptomatic and asymptomatic SARS-CoV-2 infection

M Chourasia, PR Koppula, A Battu, MM Ouseph… - Molecules, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has emerged to be the greatest threat to humanity in the …

Exploring the mechanism of action of licorice in the treatment of COVID-19 through bioinformatics analysis and molecular dynamics simulation

JF Cao, Y Gong, M Wu, X Yang, L Xiong… - Frontiers in …, 2022 - frontiersin.org
Purpose: The rapid worldwide spread of Corona Virus Disease 2019 (COVID-19) has
become not only a global challenge, but also a lack of effective clinical treatments. Studies …